Viatris
Price & Volume
Stats
See more52W Range | $6.75-$13.19 |
Market Cap | $10.6B |
Shares Short | 39M |
Financials
See moreRevenue (12 Mos) | $14.3B |
Revenue Growth (YoY) | -11.2% |
Gross Profit (12 Mos) | $5.8B |
Diluted EPS | -$3.18 |
News
See moreYahoo Finance • 8 hours ago
US FDA advisers vote against Otsuka's PTSD combination treatment
Yahoo Finance • 14 hours ago
Viatris stock unchanged as Goldman maintains Neutral rating on trial miss
Yahoo Finance • 15 hours ago
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Geron Corporation, Viatris, Everus Construction, and SoundHound
Yahoo Finance • 17 hours ago
Viatris stock falls after Phase 3 blepharitis study misses endpoint
About
CEO | Mr. Scott Andrew Smith Ph.D. |
Address | Robert J. Coury Global Center, Canonsburg, PA, United States, 15317 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 32,000 |
